Empowering precision oncology with AI-driven insights
Tempus is a healthcare technology company advancing the use of AI in precision oncology. By integrating comprehensive molecular and clinical data, we deliver actionable insights that help oncologists make more informed decisions throughout the patient journey.
Access a comprehensive oncology diagnostic portfolio to inform patient care at every step of the journey
Tempus offers a robust portfolio of tests—from germline and somatic testing to MRD and treatment response monitoring—providing a complete patient view to support clinical decisions.
Ready to order a test?
Hereditary Risk Assessment
41-gene panel for hereditary cancer
78-gene panel for hereditary cancer
Optional RNA add-on
13-gene panel for hereditary breast cancer
MRD & Response Monitoring
Tumor-naive MRD assay
Tumor-informed MRD and IO monitoring assay
Tailored Testing Add-ons
HRD, UGT1A1, DPYD, IPS, TO, PurIST®
MMR, CLDN18, PD-L1, HER2, FOLR1, MGMT, C-MET, 1p/19q
RightMed®
Leverage rigorously validated insights to guide confident clinical decision-making
Every Tempus solution is grounded in science and supported by real-world evidence. Our insights help translate molecular data into meaningful action for every patient.
2K+ publications in leading scientific journals
Dual tissue + liquid testing
DNA + RNA sequencing
Solid tumor + normal match
Streamline care with solutions that are seamlessly integrated into your existing workflows
Tempus solutions are built to work within your EHR and practice, making it easy to access insights, order tests, and take action—when and where you need them.
Easy access to current treatment options and relevant insights through our integration and connectivity capabilities.
Fast, reliable platform for ordering Tempus tests, accessing patient insights, and utilizing our AI-driven technologies seamlessly.
Providing access to patient insight directly at your fingertips with our AI-enabled clinical assistant.
Obtain affordable and accessible testing through financial assistance
Tempus offers a transparent financial assistance program for all U.S. patients, ensuring cost is not a barrier to accessing high-quality molecular testing.
All U.S.-based patients are eligible to apply for financial assistance regardless of insurance status. For international patients, we offer a self-pay option. If you have any questions, please email patients@tempus.com. Authorization for Medical Records: Through access.tempus.com, applicants are directed to our Notice and Authorization for Medical Records authorization form. This optional form allows us to request outcomes and other medical records from your health care providers. Please see the form for more information.
Applications for financial assistance can be submitted online at access.tempus.com ↗
If approved, the maximum out of pocket cost for testing will be provided immediately.
Please contact billing@tempus.com if you are concerned about out-of-pocket costs and would like to discuss your options.
Grow your precision medicine programs and reach more patients
Tempus is more than a lab—we're a strategic partner. Whether you're scaling a precision medicine program or optimizing one already in place, we offer support to help you expand access, increase trial enrollment, and deliver breakthrough care to patients.
Empowering you to deliver the next step in a patient’s care journey with our AI-enabled care pathway intelligence platform.
Just-in-time clinical trial options for patients based on clinical and molecular data, for enrollment at your institution, through our TIME Trial Program—in days instead of months.
AI capabilities to help pathologists find actionable markers in specimens to identify potential patients for clinical trials or precision therapeutics.
Participating institutions receive access to technical support, customized to meet the unique needs and goals of your cancer center.
Trusted by thousands of oncologists
We partner with community practices and more than 50% of all academic medical centers in the United States.
Making an impact in real-world care
OhioHealth
In the rapidly changing world of cancer care and precision medicine, Tempus is the established leader. They provide rapid, accurate results while also continuing to develop innovative strategies to improve patient outcomes. With a focus on both clearly defining actionable mutations and extending treatment options by matching specific patients to specific local and national studies, Tempus is directly changing the patients lives.
Cleveland Clinic
Breast cancer care has involved use of biomarkers for years in order to determine appropriate therapy. Genomic information has now been added to the list of crucial biomarkers needed to know how to treat metastatic breast cancer patients with the approval of targeted therapy for BRCA and PIK3CA mutations. Having this information also gives a patient the best opportunity to consider one of numerous biomarker driven clinical trials. These options allow as personalized an approach to treatment as possible and I have no doubt that genomic data will continue to transform the way patients are treated as our field moves forward.
This is AI-enabled precision medicine
This is the future of healthcare.